Pharmaceutical gastro-retentive systems;Sistemas farmacêuticos gastrorretentivos flutuantes

Revista Brasileira de Ciencias Farmaceuticas/Brazilian Journal of Pharmaceutical Sciences

Volumn 43, Issue 3, 2007, Pages 325-334

  Barrocas, Pedro Miguel Da Costa ^a   Santos, Delfim Fernando Gonçalves ^a   Ferreira, Domingos Carvalho ^a   Coelho, Pedro Miguel Barata De Silva ^a,b   Oliveira, Rita Cristina Sanches ^a,b   Veiga, Francisco José De Baptista ^c  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSIDADE FERNANDO PESSOA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Effervescent systems; Floating devices; Gastro retentive systems; Modified release pharmaceutics

Indexed keywords

ALGINIC ACID; AMOXICILLIN; CARRAGEENAN; CHITOSAN; CITRIC ACID; COLESTYRAMINE; METHYLCELLULOSE; PEPSTATIN; POLYACRYLIC ACID; RIBOFLAVIN; SODIUM CARBONATE; TARTARIC ACID;

CONTROLLED DRUG RELEASE; DEVICE; DRUG RELEASE; DRUG RETENTION; DRUG TISSUE LEVEL; EFFERVESCENT TABLET; FLOATING DEVICE; GASTROINTESTINAL TRACT; MEAN RESIDENCE TIME; NONHUMAN; REVIEW;

EID: 44349175005     PISSN: 15169332     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-93322007000300002     Document Type: Review

References (53)

1. AMINABHAVI, M.; ANANDRAO, R.; KULKARNI, Inicial?; KUMARESH, S.; SOPPIMATH T. Development of hollow microspheres as floating controlled release systems for cardiovascular drugs: preparation and release characterisitics. Drug Dev. Ind. Pharm., v.27, n.6, p.507-515, 2001.
2. ATYABI, H. L.; SHARMA, H. A. H.; MOHAMMAD, J.T.; FELL, Inicial. A novel floating system using ion exchange resins. Proc. Int. Symp. Control. Release Bioact. Mater., v.21, p.806-807, 1994.
3. ATYABI, R. L.; SHARMA, H. A. R.; MOHAMMAD, .T.; FELL, Inicial? In vivo evaluation of a novel gastric retentive formulation based on ion exchange resins. J. Control. Release, v.42, p. 105-113, 1996.
4. BAGGESEN, H.; BECHGAARD, S. Propoxyphene and norpropoxyphene: influence of type of controlled release formulation on intra-and inter-subject variations. J. Pharm.Sci., v.69, n.11, p.1327-1330, 1980.
5. BAUMGARTNER, J.; KRISTL, F.; VRECER, P.; VODOPIVEC, B.; ZORKO, ?. Optimisation of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm., v.195, n.1-2, p.125-135, 2000.
6. BERNABEI, V.; IANNUCCELLI, G.; COPPI, M. T. R; CAMERONI, Inicial? Air compartment multiple-unit system for prolonged gastric residence. Part I. Formulation study. Int. J. Pharm., v.174, p. 47-54, 1998.
7. BI, D.; WEI, Z.; ZHANFENG,Y. Design and evaluation of a two-layer floating tablet for gastric retention using cisapride as a Model Drug. Drug Dev. Ind. Pharm, v.27, n.5, p.469-474, 2001.
8. BADRA, D.; UMAMAHESHWARI, R. B.; SUBHEET, Inicial?; JAIN, N. K.; JAIN, A. New approach in gastroretentive drug delivery system using cholestyramine. Drug Del., v.10, p.151-160, 2003.
9. BOLTON, S.; DESAI, S. A floating controlled-release drug delivery systems: in vitro-in vivo evaluation. Pharm. Res., v.10, p.1321-1325, 1993.
10. BOLTON, S.; DESAI, S. Floating sustained release therapeutic compositions. US Patent 4,814, 179, March 21, 1989.
11. BURI, P.; ROUGE, N.; DOELKER, E. Drug absortion sites in gastrointestinal tract and dosage forms for site- specific delivery. Int. J. Pharm., v.136, p.117-139, 1996.
12. CHANG, H. S. H.; PARK, P.; KELLY, ROBINSON, J. R. Bioadhesive polymers as platforms for oral controlled drug delivery II. Synthesis and evaluation of some swelling, water insoluble polymers. J. Pharm. Sci., v.74, n.4, p.399-405, 1985.
13. CHITNIS, V.S.; MALSHE, V.S.; LALLA, I.K. Bioadhesive polymers-synthesis, evaluation and application in controlled release tablets. Drug Dev. Ind. Pharm., v.17, p.879-892, 1991.
14. COLLETT, L.; WHITEHEAD, J. T.; FELL, J.R. Development of a gastroretentive dosage form. Eur. I Pharm. Sci., v.4 (suppl.), S182, 1996.
15. COLLETT, L.; WHITEHEAD, J.T.; FELL, J. R.; SHARMA, H.L.; SMITH, A-M.Floating dosage forms: an in vivo study demonstrating prolonged gastric retention. J. Control. Release, v.55, p.3-12, 1998.
16. COLLET, J. T.; FELL, L.; WHITEHEAD, H. Prolonged gastric retention using floating dosage forms. Pharm. Technol., v.24, n.3, p.82-90, 2000.
17. COPPI, G.; IANNUCCELLI, V. R.; SANSONE, G. FROLLA. Air compartment multiple-unit system for prolonged gastric residence. Part II In vivo evaluation. Int. J. Pharm., v.174, p.55-62, 1998.
18. DAVE, S.B.; AMIN, A.F.; PATEL, M. Gastoretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation. AAPS Pharmscitech, v.5, n.2, p.34, 2004.
19. DAVIS, S.S.; STOCKWELL, A.F.; WALKER, S.E. In vitro evaluation of alginate gel systems as sustained release drug delivery systems. J. Control. Release, v.3, n.167-175, 1986.
20. DEASY, P.B.; HILTON, A.K. In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate. Int. J. Pharm., v.86, p.79-88,1992.
21. DENNIS, A.; TIMMINS, P.; LEE, K., Buoyant controlled release powder formulation. US Patent 5, 169,638, December 8, 1992.
22. DESHPANDE, A. A.; RHODES, C. T.; SHAH, N. H.; MALICK, A. W. Controlled-release drug delivery systems for prolonged gastric residence: an overview. Drug. Dev. Ind. Pharm., v.22, n.6, p.531-539, 1996.
23. ESHRAGHI, J.; YANG, L.; FASSIHI, R. A new intragastric delivery system for the treatment of 1 Helicobacter pylori associated gastric ulcer: in vitro evaluation. J. Control. Release, v.57, p.215-222, 1999.
24. FELL, J. T. Delivery systems for targeting to specific sites in gastrointestinal tract. J. Pharm. Pharmacol., v.51 (suppl), p.41, 1999.
25. FRANZ, M.R.; OTH, M.P. Sustained release, bilayer buoyant dosage form. US Patent 5, 232, 704, August 3, 1993.
26. FRIEND, D.R.; RUBINSTEIN, A. Polymeric site-specific pharmacotherapy. Chichester: Wiley, 1994.
27. FRYERS, G.R.; TODD. R.S. Cholestyramine compositions and method for treating biliary gastritis. US Patent 4, 172, 120, 1979.
28. HARRIGAN, R.M. Drug delivery device for preventing contact of undissolved drug with the stomach lining. US Patent 4,055, 178, 1977.
29. HINO, T.; KAWASHIMA, Y.; NIWA, H.; TAKEUEHI, T.; ITO, Y., Preparation of multiple hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristic (in vitro) and floating behaviour (in vivo). J. Control. Release, v.16, p.279-290, 1991.
30. HINO, T.; KAWASHIMA, T.; NIWA, H.; TAKEUCHI, T.; ITOH, Y.; Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J. Pharm. Sci., v.81, p.135-140, 1992.
31. IBRAHIM EL-GIBALY. Development and in vitro evaluation of novel floating quitosano microcapsules for oral use: comparison with non-floating chitosan microspheres. Int. J. Phar., v.249, p.7-21, 2002.
32. ICHIKAWA, M.; WATANABE, S.; MIYAKE, Y. Granule remaining in stomach US Patent 4, 844,905, 1989.
33. INOUYE, K.; MACHIDA, Y.; SANNAN, T.; NAGAI, T. Buoyant sustained release tablets based on chitosan. Drug Des. Del., v.2, p.165-175,1988.
34. INOUYE, K.; MACHIDA, Y.; SANNAN, T.; NAGAI, T. Buoyant sustained release granules based on chitosan. Drug Des. Del., v.4, p.55-67,1989.
35. ISHINO, Y.; WATANABE, S.; KAYANO, M.; MIYAO, K. Solid therapeutic preparation remaining in stomach. US Patent 3,976, 764,1976.
36. JAYAKRISHNAN, A.; THANOO, B.C.; SUNNY, M.C. Oral sustained-release drug delivery systems using polycarbonate microspheres capable of floating on the gastricfluid. J. Pharm. Pharmacol., v.45, p.21-24, 1993.
37. JAYAKRISHNAN, A.; JOSEPH, N.J.; LAKSHMI, S. A floating-type oral dosage form for piroxicam based on hollow polycarbonate microspheres: in vitro and in vivo evaluation in rabbits. J. Control. Release, v.79, p.71-79, 2002.
38. KAWASHIMA, Y.; SATO, Y.; TAKEUCHI, H.; YAMAMOTO, H. In vitro and in vivo evaluation of riboflavin-containing microballoons for a floating controlled drug delivery system in healthy humans. Int. J. Phar., v.275, p.97-107, 2004.
39. LOSI, E.; BETTINI, R.; SANTI, P.; SONVICO, F.; COLOMBO, G.; LOFTHUS, K.; COLOMBO, P.; PEPPAS, N.A. Assemblage of novel release modules for the development of adaptable drug delivery systems. J. Control. Release, v.111, n.1-2, 10, p.212-218, 2006.
40. MATHARU, R. S.; SANGHAVI, N. M. Novel drug delivery system for captopril. Drug Dev. Ind. Pharm., v.18, p.1576-157?, 1992.
41. MICHAELS, A.S. Drug delivery device with self actuated mechanism for retaining device in selected area. US Patent 3, 786, 813, 1974
42. MITRA, S.B. Sustained release oral medicinal delivery device. US Patent 4, 451,260, 1984.
43. MIYAZAKI, S.; YAMAGUCHI, H.; YOKOUCHI, C.; TAKADA, M.; HOU, W.M. Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. Chem. Pharn. Bull., v.36, p.4033-4038, 1988.
44. NAKAMIEHI, K.; USHIMARU, K.; SAITO, R. Pharmaceutical preparations and a method of manufacturing them. US Patent 4,702,918, 1987
45. PARK, K.; ROBINSON, J., Bioadhesive polymers as platform for oral-controlled drug delivery: method to study bioadhesion, Int. J. Pharm., v.19, n.1, p.107-127, 1984.
46. RITSEHEL, W.A. Targeting in the gastrointestinal tract: new approaches; Methods Find. Exp. Clin. Pharmacol., v.13, p.313-336, 1991.
47. SHETH, P.R.; TOSSOUNIAN, J.L. Sustained release pharmaceutical capsules. US Patent 4, 126,672, 1978.
48. SHETH, P. R.; TOSSOUNIAN J.L. Novel sustained release tablet formulations. US Patent 4, 167,558, 1979.
49. SHETH P.R.; TOSSOUNIAN J.L. Sustained release tablet formulations. US Patent 4, 140, 755, 1979.
50. SHETH, P.R.; TOSSOUNIAN J.L. The hydrodynamically balanced system (HBSTM): a novel drug delivery system for oral use. Drug Dev. Ind. Pharm., v.10, p.313-339, 1984.
51. TORRADO, S.; DE LA TORRE, P.M.; TORRADO, G. Poly (acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery. J Biomed Mater Res B Appl Biomater, v.72, n.1, p.191-197, 2005.
52. UMEZAWA, H. Pepstatin floating minicapsules. US Patent 4, 101,650,1978
53. XIAOQIANG, X.; MINJIE, S.; FENG, Z.; YIQIAO, H. Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: In vitro and in vivo evaluation in healthy volunteers. Inter. J. Pharmac., v.310, n.1-2, 9, p.139-145, 2006.